Login / Signup

Prevalence of growth hormone deficiency in patients with unexplained chronic fatigue after undergoing bone marrow transplantation in adulthood.

N SaadA MahajanA ChinD StewartGregory A Kline
Published in: Journal of endocrinological investigation (2021)
GHD may be a treatable explanation for disabling post-BMT fatigue pending results of intervention studies.
Keyphrases
  • growth hormone
  • bone marrow
  • sleep quality
  • randomized controlled trial
  • mesenchymal stem cells
  • depressive symptoms
  • risk factors
  • case control
  • cell therapy
  • early life
  • replacement therapy
  • drug induced